ArticleBMC endocrine disorders2025
Monocyte-to-lymphocyte ratio as an inflammatory biomarker for predicting diabetic peripheral neuropathy in type 2 diabetes mellitus patients.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) is an intricate metabolic disorder often accompanied by low-grade inflammation. This study aimed to investigate the relationship between the monocyte-to-lymphocyte ratio (MLR) and diabetic peripheral neuropathy (DPN) in patients with T2DM.
methodA total of 236 individuals diagnosed with T2DM participated in the research. Clinical parameters were assessed, including the Toronto Clinical Neuropathy Score (TCNS), Compound Muscle Action Potential (CMAP), Sensory Nerve Action Potential (SNAP), nerve conduction velocity (NCV), complete blood count, biochemical markers, and inflammatory indicators. These parameters were analyzed and compared, followed by logistic regression and receiver operating characteristic (ROC) curve analyses.
resultsThe findings demonstrated that patients with DPN were generally older and had higher MLR levels and glycated hemoglobin levels, lower high-density lipoprotein cholesterol(HDL-C), longer disease duration, and higher FPG compared to patients without DPN. Additionally, CMAP and SNAP of median nerve (MN), ulnar nerve(UN), peroneal nerve (PN), and tibial nerve (TN) were significantly lower in the higher MLR group than in the higher MLR group( P < 0.05). ROC analysis indicated that MLR had an area under the curve (AUC) of 0.625, suggesting a limited discriminative ability to identify DPN.
conclusionThis study underscores the potential ability of MLR as a predictive biomarker for DPN in patients with T2DM, emphasizing the important role of inflammation in the development of this condition. But it has a low performance for DPN diagnosis. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.